IDEX (NYSE: IEX) boosts buyback, total authorization about $1B

Rhea-AI Filing Summary

IDEX Corporation disclosed that its Board of Directors authorized an additional $635 million for repurchases of the company’s common shares. When combined with approximately $365 million remaining under prior authorizations, the company now has a total share repurchase authorization of about $1 billion.

The company states that repurchases may occur from time to time through open market or privately negotiated transactions and may also be executed under Rule 10b5-1 plans. Management will determine the timing, volume and nature of repurchases based on market conditions, cash investment priorities, applicable securities laws and other factors, and the program can be suspended or discontinued at any time.

Insights

Equity & capital allocation analyst

IDEX adds $635M, lifting total share repurchase capacity to about $1B.

IDEX Corporation has increased its authorized share repurchase capacity by $635 million, bringing total authorization to roughly $1 billion when combined with prior unused approvals. This represents a substantial pool the company may use to buy back common shares over time.

The company notes that repurchases may occur via open market or privately negotiated transactions and may also be executed under Rule 10b5-1 trading plans. Decisions on timing, volume and method are left to management and depend on market conditions, other cash investment priorities, applicable securities laws and additional factors.

The authorization is explicitly discretionary and can be suspended or discontinued at any time, so the actual level of repurchases will depend on future management decisions rather than this approval alone. Future company filings and the attached press release dated September 18, 2025 may provide more detail on how and when the authorization is used.

8-K Event Classification

3 items: 7.01, 8.01, 9.01

3 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000832101false00008321012025-09-172025-09-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report: September 17, 2025

(Date of earliest event reported)

IDEX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

1-10235

36-3555336

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of incorporation)

Identification No.)

3100 Sanders Road, Suite 301

Northbrook, Illinois 60062

(Address of principal executive offices, including zip code)

(847) 498-7070

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $.01 per share

IEX

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 - Regulation FD Disclosure.

A copy of the press release relating to the matter described below is attached hereto as Exhibit 99.1 and is furnished herewith.

Item 8.01 - Results of Operations and Financial Condition.

On September 17, 2025, the Board of Directors of IDEX Corporation (the “Company”) authorized the repurchase of an additional $635 million of the Company’s common shares. The increased repurchase authorization, when added to the approximately $365 million that remained available from the previously approved repurchase authorizations, provides the Company with a total authorized repurchase availability of approximately $1 billion.

The repurchases will be made from time to time in either open market transactions or in privately negotiated transactions, and may also be made under 10b5-1 plans. The timing, volume and nature of share repurchases will be at the discretion of management, dependent on market conditions, other priorities of cash investment, applicable securities laws and other factors. This share repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or discontinued at any time.

Item 9.01 – Financial Statements and Exhibits.

(d)    Exhibits

99.1    Press release dated September 18, 2025 announcing IDEX Corporation’s additional share repurchase authorization.

.

104.0     Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IDEX CORPORATION
			By:			/s/    AKHIL MAHENDRA
						Akhil Mahendra
						Interim Chief Financial Officer and Vice President, Corporate Development
September 18, 2025

FAQ

What share repurchase action did IDEX (IEX) announce in this 8-K?

The Board of Directors of IDEX Corporation authorized the repurchase of an additional $635 million of the company’s common shares.

What is IDEX Corporation’s total share repurchase authorization after this increase?

After adding the new authorization to approximately $365 million that remained from prior approvals, IDEX Corporation now has about $1 billion in total authorized share repurchase capacity.

How may IDEX (IEX) execute its share repurchases?

IDEX Corporation states that repurchases may be made from time to time in open market transactions or privately negotiated transactions, and may also be carried out under Rule 10b5-1 plans.

Is IDEX obligated to repurchase a specific amount of stock under this program?

No. The company explains that the share repurchase program does not obligate it to acquire any particular amount of common stock and that it may be suspended or discontinued at any time.

What factors will influence IDEX’s decisions on share repurchases?

IDEX Corporation indicates that management will determine the timing, volume and nature of repurchases based on market conditions, other priorities of cash investment, applicable securities laws and other factors.

What exhibit accompanied IDEX Corporation’s 8-K about the repurchase authorization?

The filing includes Exhibit 99.1, a press release dated September 18, 2025 announcing IDEX Corporation’s additional share repurchase authorization.